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Grant and Glidden present interesting data from the iPrEx trial [1]. In contrast to their 
findings, the PROUD study did not show a major reduction over time in risky sexual 
behaviour. The Figure shows the number of different partners with whom 
participants reported condomless receptive anal sex in the 90 days prior to visits at 
enrolment, 12 months, and 24 months. In both the immediate and deferred PrEP groups, 
about 80% of participants reported one or more partners at 12 months and at 24 months (not 
necessarily the same individuals). Thus for most men it was appropriate to continue 
prescribing PrEP, suggesting that subpopulations might exist who need the drug for a longer 
time than suggested by the iPrEx data. We note (1) the iPrEx analysis is 
limited to seroconverters who, by definition, were at especially high risk of HIV 
infection; (2) the PROUD analysis [2] excludes men who stopped attending clinic and 
who may have been at lower risk. These factors may partially explain the difference 
between the findings of these two analyses. 
 
Nonetheless, we agree with Grant’s and Glidden’s key point about individual 
variation in the risk of acquiring HIV infection, including periods of no or low risk. 
Given this, we were surprised that they did not mention the IPERGAY study [3], which 
found that intermittent PrEP (two tablets before sex and a further two tablets after sex) 
was highly effective. This is arguably a more logical and cost-effective approach 
than daily dosing for individuals who “pass through HIV risk moments” rather than 
being at continuous significant risk. PrEP guidelines for the MSM population at risk 
of HIV currently lack uniformity: US guidelines recommend daily dosing only [4], whereas 
the European AIDS Clinical Society recommend either daily or intermittent dosing 
[5]. Further evaluation is required to determine the optimal way to promote and deliver 
PrEP in different populations, taking account of the wide range of behaviours and the 
need to tailor regimens to individual circumstances. 
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Figure legend 
Number of partners with whom participants reported condomless receptive anal sex in 
previous 90 days. 
 
Footnote: Based on 515 values at baseline, 406 values at 12 months, 244 values at 24 
months. Further data will become available at 24 months with continued follow-up. 
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